Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-10

Clinical Trial Update: The Effect of Varenicline (Chantix) and Bupropion (Zyban) on Smoking Lapse Behavior [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effects of varenicline and bupropion on smoking lapse behavior, completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)
  • bupropion (bupropion)

Snippet

Sponsor: Yale University | Conditions: Smoking Lapse Behavior | Phase 2 | Status: COMPLETED | Results posted: 2017-03-10